LONDON — A coronavirus vaccine developed by drug firm AstraZeneca and Oxford University has shown 70 percent effectiveness in trials involved 23,000 people, they said in a statement on Monday.
The announcement comes after other trials of drugs developed by Pfizer/BioNTech and Moderna announced effectiveness above 90 percent.
The results ranged between 62 and 90 percent efficacy depending on the vaccine dosage, according to Monday’s statement.
AstraZeneca chief executive Pascal Soriot said his firm’s vaccine would still be highly effective and would have an “immediate impact”.
The firm said it would look to develop up to three billion doses of the vaccine in 2021 if it p…
Keep on reading: AstraZeneca/Oxford vaccine 70% effective at tackling coronavirus